Long-Term Stable Mixed Chimerism after Hematopoietic Stem Cell Transplantation in Patients with Non-Malignant Disease, Shall We Be Tolerant?

Arwen Stikvoort; Mikael Sundin; Mehmet Uzunel; Jens Gertow; Berit Sundberg; Marie Schaffer; Jonas Mattsson; Michael Uhlin

doi:10.1371/journal.pone.0154737

Loading metrics

Open Access

Peer-reviewed

Research Article

Long-Term Stable Mixed Chimerism after Hematopoietic Stem Cell Transplantation in Patients with Non-Malignant Disease, Shall We Be Tolerant?

Arwen Stikvoort ,

* E-mail: arwen.stikvoort@ki.se (AS); michael.uhlin@ki.se (MU)

Affiliations Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden, Centre for Allogeneic Stem Cell Transplantation (CAST), Karolinska University Hospital, Stockholm, Sweden
⨯
Mikael Sundin,

Affiliations Division of Paediatrics, Department of Clinical Sciences, Intervention and Technology (CLINTEC), Karolinska Institute, Stockholm, Sweden, Hematology/Immunology/HSCT Section, Astrid Lindgren Children’s Hospital, Karolinska University Hospital, Stockholm, Sweden
⨯
Mehmet Uzunel,

Affiliation Centre for Allogeneic Stem Cell Transplantation (CAST), Karolinska University Hospital, Stockholm, Sweden
⨯
Jens Gertow,

Affiliation Centre for Allogeneic Stem Cell Transplantation (CAST), Karolinska University Hospital, Stockholm, Sweden
⨯
Berit Sundberg,

Affiliations Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden, Centre for Allogeneic Stem Cell Transplantation (CAST), Karolinska University Hospital, Stockholm, Sweden
⨯
Marie Schaffer,

Affiliation Department of clinical immunology and transfusion medicine, Karolinska University Hospital, Stockholm, Sweden
⨯
Jonas Mattsson,

Affiliations Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden, Centre for Allogeneic Stem Cell Transplantation (CAST), Karolinska University Hospital, Stockholm, Sweden
⨯
Michael Uhlin

* E-mail: arwen.stikvoort@ki.se (AS); michael.uhlin@ki.se (MU)

Affiliations Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden, Centre for Allogeneic Stem Cell Transplantation (CAST), Karolinska University Hospital, Stockholm, Sweden, Department of clinical immunology and transfusion medicine, Karolinska University Hospital, Stockholm, Sweden
⨯

Long-Term Stable Mixed Chimerism after Hematopoietic Stem Cell Transplantation in Patients with Non-Malignant Disease, Shall We Be Tolerant?

Arwen Stikvoort,
Mikael Sundin,
Mehmet Uzunel,
Jens Gertow,
Berit Sundberg,
Marie Schaffer,
Jonas Mattsson,
Michael Uhlin

Published: May 6, 2016
https://doi.org/10.1371/journal.pone.0154737

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

T cells
Is the Subject Area "T cells" applicable to this article?

Thanks for your feedback.
Lymphocytes
Is the Subject Area "Lymphocytes" applicable to this article?

Thanks for your feedback.
Cytokines
Is the Subject Area "Cytokines" applicable to this article?

Thanks for your feedback.
Cytotoxic T cells
Is the Subject Area "Cytotoxic T cells" applicable to this article?

Thanks for your feedback.
Platelets
Is the Subject Area "Platelets" applicable to this article?

Thanks for your feedback.
Computer software
Is the Subject Area "Computer software" applicable to this article?

Thanks for your feedback.
Fluorescence-activated cell sorting
Is the Subject Area "Fluorescence-activated cell sorting" applicable to this article?

Thanks for your feedback.
Hematopoietic stem cell transplantation
Is the Subject Area "Hematopoietic stem cell transplantation" applicable to this article?

Thanks for your feedback.